» Articles » PMID: 18404507

P2X(7) Receptor: Death or Life?

Overview
Publisher Springer
Date 2008 Apr 12
PMID 18404507
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

The P2X(7) plasma membrane receptor is an intriguing molecule that is endowed with the ability to kill cells, as well as to activate many responses and even stimulate proliferation. Here, the authors give an overview on the multiplicity and complexity of P2X(7)-mediated responses, discussing recent information on this receptor. Particular attention has been paid to early and late signs of apoptosis and necrosis linked to activation of the receptor and to the emerging field of P2X(7) function in carcinogenesis.

Citing Articles

Increased Pan-Type, A1-Type, and A2-Type Astrocyte Activation and Upstream Inflammatory Markers Are Induced by the P2X7 Receptor.

Campagno K, Sripinun P, See L, Li J, Lu W, Jassim A Int J Mol Sci. 2024; 25(16).

PMID: 39201471 PMC: 11354399. DOI: 10.3390/ijms25168784.


Extracellular ATP/P2X7 receptor, a regulatory axis of migration in ovarian carcinoma-derived cells.

Nunez-Rios J, Reyna-Jeldes M, Mata-Martinez E, Campos-Contreras A, Lazcano-Sanchez I, Gonzalez-Gallardo A PLoS One. 2024; 19(6):e0304062.

PMID: 38870128 PMC: 11175443. DOI: 10.1371/journal.pone.0304062.


Exploring the Three-Dimensional Frontier: Advancements in MSC Spheroids and Their Implications for Breast Cancer and Personalized Regenerative Therapies.

Smolinska V, Harsanyi S, Bohac M, Danisovic L Biomedicines. 2024; 12(1).

PMID: 38255159 PMC: 10813175. DOI: 10.3390/biomedicines12010052.


The P2X7 Receptor in Oncogenesis and Metastatic Dissemination: New Insights on Vesicular Release and Adenosinergic Crosstalk.

Adinolfi E, De Marchi E, Grignolo M, Szymczak B, Pegoraro A Int J Mol Sci. 2023; 24(18).

PMID: 37762206 PMC: 10531279. DOI: 10.3390/ijms241813906.


Purinergic signaling: Diverse effects and therapeutic potential in cancer.

Kaur J, Dora S Front Oncol. 2023; 13:1058371.

PMID: 36741002 PMC: 9889871. DOI: 10.3389/fonc.2023.1058371.


References
1.
Le Stunff H, Auger R, Kanellopoulos J, Raymond M . The Pro-451 to Leu polymorphism within the C-terminal tail of P2X7 receptor impairs cell death but not phospholipase D activation in murine thymocytes. J Biol Chem. 2004; 279(17):16918-26. DOI: 10.1074/jbc.M313064200. View

2.
Rassendren F, Buell G, Virginio C, Collo G, North R, Surprenant A . The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. J Biol Chem. 1997; 272(9):5482-6. DOI: 10.1074/jbc.272.9.5482. View

3.
Alcaraz L, Baxter A, Bent J, Bowers K, Braddock M, Cladingboel D . Novel P2X7 receptor antagonists. Bioorg Med Chem Lett. 2003; 13(22):4043-6. DOI: 10.1016/j.bmcl.2003.08.033. View

4.
Lee H, Bardini M, Burnstock G . P2X receptor immunoreactivity in the male genital organs of the rat. Cell Tissue Res. 2000; 300(2):321-30. DOI: 10.1007/s004410000207. View

5.
Whitmarsh A, Davis R . Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med (Berl). 1996; 74(10):589-607. DOI: 10.1007/s001090050063. View